Use of anakinra (Kineret) in the treatment of familial cold autoinflammatory syndrome with a 16-month follow-up

Journal of Cutaneous Medicine and Surgery

Volumn 12, Issue 1, 2008, Pages 8-16

  Ross, J Barrie ^a   Finlayson, Laura A ^b   Klotz, P Jennifer ^b   Langley, Richard G ^b   Gaudet, Roxanne ^b   Thompson, Kara ^b   Churchman, Sarah M ^b   McDermott, Michael F ^b   Hawkins, Philip N ^b  

^a Bishop's Landing   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

MOMETASONE FUROATE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; FAMILIAL COLD AUTOINFLAMMATORY SYNDROME; FEMALE; FOLLOW UP; HUMAN; INJECTION SITE REACTION; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADULT; AGED; ANTIRHEUMATIC AGENTS; AUTOIMMUNE DISEASES; CANADA; COLD; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFLAMMATION; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; MALE; MIDDLE AGED; SYNDROME; TREATMENT OUTCOME; URTICARIA;

EID: 40549122679     PISSN: 12034754     EISSN: None     Source Type: Journal    
DOI: 10.2310/7750.2008.07050     Document Type: Article

References (26)

1. Kile RI, Rusk HA. A case of cold urticaria with an unusual family history. JAMA 1940;114:1067-8.
2. Zip CM, Ross JB, Greaves MW, et al. Familial cold urticaria. Clin Exp Dermatol 1993;18:338-41.
3. Tindall JP. Familial cold urticaria. A generalized reaction involving leukocytosis. Arch Intern Med 1969;124:129-34.
4. Hoffman HM, Wanderer AA, Broide DH. Familial cold autoinflammatory syndrome: phenotype and genotype of an autosomal dominant fever. J Allergy Clin Immunol 2001;108:615-20.
5. Hawkins PN, Lachmann HJ, McDermott MF. Efficacy of interleukin-1 receptor antagonist in Muckle-Wells syndrome. N Engl J Med 2003;348:2583-4.
6. Jung M, Ross B, Wienker T, et al. A locus for familial cold urticaria maps to distal chromosome 1q: familial cold urticaria and Muckle-Wells syndrome are probably allelic. Am J Hum Genet 1996;59 Suppl:A223.
7. Aganna E, Martinon F, Hawkins PN, et al. Associations of mutations in the NALP/CIAS1/PYPAF1 gene with a broad phenotype including recurrent fever, cold sensitivity, sensoneural deafness and AA amyloidosis. Arthritis Rheum 2002;46:2445-52.
8. McDermott MF. Autosomal dominant recurrent fevers. Clinical and genetic aspects. Rev Rhum 1999;66:555-63.
9. McGonagle D, McDermott MF. A proposed classification of the immunological diseases. PLOSMed 2006;3(8):e297.
10. Amgen Canada Inc. Kineret (anakinra) [product monograph]. May 24, 2002.
11. Kavanaugh A. Anakinra (interleukin-1 receptor antagonist) has positive effects on function and quality of life in patients with rheumatoid arthritis. Adv Ther 2006;23:208-17.
12. Buch MH, Bingham SJ, Seto Y, et al. Lack of response to anakinra in rheumatoid arthritis following failure of tumor necrosis factor blockade. Arthritis Rheum 2004;50:725-8.
13. Furst DE. Anakinra: review of recombinant human interleukin-I receptor antagonist in the treatment of rheumatoid arthritis. Clin Ther 2004;26:1960-75.
14. Metyas SK, Hoffman HM. Anakinra prevents symptoms of familial cold autoinflammatory syndrome and Raynaud's disease. J Rheumatol 2006;33:2085-7.
15. Chae JJ, Wood G, Masters SL, et al. The B30.2 domain of pyrin, the familial Mediterranean fever protein, interacts directly with caspase-1 to modulate IL-1beta production. PNAS 2006;103:9982-7.
16. Eda S, Kaufmann J, Molwitz M, et al. A new method of measuring C-reactive protein, with a low limit of detection, suitable for risk assessment of coronary heart disease. Scand J Clin Lab Invest 1999; 230:325.
17. Ledue TB, Weiner DL, Sipe JD, et al. Analytical evaluation of particle enhanced immunonephelometric assays for C reactive protein, serum amyloid A and mannose binding protein inhuman serum. Ann Clin Biochem 1998;35:745-53.
18. Hoffman HM, Rosengren S, Boyle DL, et al. Prevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleukin-1 receptor antagonist. Lancet 2004;364: 1779-85.
19. Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI): a simple practical measure for routine clinical use. Clin Exp Dermatol 1994;19:210-6.
20. Manji GA, Wang L, Geddes BJ, et al. PYPAF1, a PYRIN-containing Apaf1-like protein that assembles with ASC and regulates activation of NF-kappa B. J Biol Chem 2002;277:11570-5.
21. Dowds TA, Masumoto J, Chen FF, et al. Regulation of cryopyrin/Pypaf1 signaling by pyrin, the familial Mediterranean fever gene product. Biochem Biophys Res Commun 2003;302:575-80.
22. Dinarello CA. Interleukin 1 and interleukin 18 as mediators of inflammation and the aging process. Am J Clin Nutr 2006;83: 447S-55.
23. Harigai M, Hara M, Kitani A, et al. Interleukin 1 and tumor necrosis factor-alpha synergistically increase the production of interleukin 6 in human synovial fibroblast. J Clin Lab Immunol 1991;34:107-13.
24. Mirault T, Launay D, Cuisset L, et al. Recovery from deafness in a patient with Muckle-Wells syndrome treated with anakinra. Arthritis Rheum 2006;54:1697-700.
25. Goldbach-Mansky R, Dailey NJ, Canna SW, et al. Neonatal-onset multisystem inflammatory disease responsive to interleukin-1β inhibition. N Engl J Med 2006;355:581-92.
26. O'Connell SM, O'Regan GM, Bolger T, et al. Response to IL-1-receptor antagonist in a child with familial cold autoinflammatory syndrome. Pediatr Dermatol 2007;24:85-9.